Nearly 1 in 8 Americans older than 12 used illicit substances in 2018, including misuse of prescription medications. In addition, more than 80% of those who would benefit from substance use treatment in the past year did not receive it. Thus, the importance of identifying and offering treatment should be a priority — particularly in primary care settings. However, there are many barriers to implementing unhealthy substance use screening including pervasive stigma, lack of clinician comfort, logistics, and limited knowledge of or avenues for treatment when unhealthy drug use is uncovered. The US Preventative Services Task Force (USPSTF) recently published updated recommendations on drug use screening.
Guest Authors: Melissa C. Palmer, PharmD, BCPS, BCPP; Jordan Cooler, PharmD, BCPP; and Amanda Stahnke, PharmD, BCACP
Music by Good Talk
An Incli-ng of Benefit? Efficacy and Safety of Inclisiran for Elevated LDL
Will Riva Be Defeated By It’s (Long-Standing) Nemesis, Apixa?
Should Penicillin Allergy Skin Testing be a Thing of the PAST?
Does Long-Term Proton Pump Inhibitor Use Pump Up Your Risk of Adverse Effects?
Is the Grass Really Greener? Cognitive Function After Discontinuation of Cannabis
A CLEAN Sweep: Getting Rid of the Medication Cost Barrier
Should Bedtime be Med-Time for Hypertension?
Let’s COLCOT to the Chase: Colchicine for Secondary Prevention of CV Events
Don’t Let Numbers Fool You: Levothyroxine Isn’t a Cure-all
Age is Just a Number: Discontinue Statins with Care
A Cause for a PAUSE: Evaluating a Standardized Perioperative DOAC Management Protocol
Who CARES? Getting to the Heart of Allopurinol and Febuxostat CV Outcomes
Up in Flames: Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease Receiving Anticoagulation for A-fib
Is Dapagliflozin aDAPtAble to Treating HFrEF in Patients Without Diabetes?
Are Older Adults with Heart Failure Self-Care Aware?
Secondary Stroke Prevention in A-Fib: Do DOACs PROSPER in High-Risk Patients?
Under Pressure: Does Directly Observing Medication Administration Lower Blood Pressure?
Will Oral Semaglutide PIONEER the Way to Lower Cardiovascular Risk?
Using CRP in COPD to Guide Treatment Decisions During Exacerbations
Addressing the Adherence Problem: Do Med Sync Programs Really Work?
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive